施万细胞在糖尿病周围神经病变中的作用研究进展

郝彤; 曹涛; 计鹏; 张伟锋; 陶克

doi:10.3760/cma.j.cn501225-20230727-00019

施万细胞在糖尿病周围神经病变中的作用研究进展

doi: 10.3760/cma.j.cn501225-20230727-00019

郝彤¹,
曹涛²,
计鹏¹,
张伟锋³,
陶克^4, ,

1.
空军军医大学第一附属医院全军烧伤中心，烧伤与皮肤外科，西安　　710032
2.
解放军63600部队医院外二科，酒泉　　735000
3.
陕西师范大学生命科学学院生物化学系，西安　　710062
4.
温州医科大学附属第一医院创面修复与再生医学中心创面修复科，温州　　325015

基金项目:

国家自然科学基金面上项目 82272269

详细信息

通讯作者:
陶克，Email：tao-ke2001@163.com

计量
- 文章访问数: 178
- HTML全文浏览量: 186
- PDF下载量: 32
- 被引次数: 0
出版历程
- 收稿日期: 2023-07-27
- 网络出版日期: 2023-12-19

Research advances on the role of Schwann cells in diabetic peripheral neuropathy

Hao Tong¹,
Cao Tao²,
Ji Peng¹,
Zhang Weifeng³,
Tao Ke^{4
, ,}

1.
Department of Burns and Cutaneous Surgery, Burn Center of PLA, the First Affiliated Hospital of Air Force Medical University, Xi'an 710032, China
2.
The Second Department of Surgery, 63600 PLA Hospital, Jiuquan 735000, China
3.
Department of Biochemistry, College of Life Sciences, Shaanxi Normal University, Xi'an 710062, China
4.
Department of Wound Repair, Center for Wound Repair and Regenerative Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China

Funds:

General Program of National Natural Science Foundation of China 82272269

More Information

Corresponding author: Tao Ke, Email: tao-ke2001@163.com

摘要

摘要: 糖尿病周围神经病变（DPN）是糖尿病常见的慢性并发症之一，常导致脊神经、颅神经以及植物神经病变，其中以糖尿病远端对称性多发性神经病变最具代表性，包括双侧肢体疼痛、麻木和感觉异常等症状，是引起糖尿病足溃疡（DFU）的主要原因之一。施万细胞是外周神经系统中主要的神经胶质细胞，在神经损伤后的修复中起着至关重要的作用。施万细胞作为慢性高糖损伤的靶点细胞，其功能包括形成髓鞘、分泌神经营养因子、对轴突进行能量供应和引导轴突再生等在高糖作用下遭到破坏，从而抑制受损神经的修复，加速DPN的进展。因此，如能有效减轻高糖对施万细胞的损伤，将会为DPN和DFU的治疗及降低DFU的发病率提供新的途径。该文重点就施万细胞的功能及其与DPN的关系进行综述。
- 糖尿病足 /
- 髓鞘 /
- 糖尿病周围神经病变 /
- 施万细胞 /
- 神经营养因子 /
- 能量供应 /
- 轴突再生
Abstract: Diabetic peripheral neuropathy (DPN) is one of the common chronic complications of diabetes, resulting in neuropathy of spinal nerve, cranial nerve, and vegetative nerve. Diabetic distal symmetric multiple neuropathy is the most representative lesion of DPN, including symptoms of bilateral limbs pain, numbness, and paresthesia, etc. DPN is one of the main reasons causing diabetic foot ulcer (DFU). Schwann cells (SCs) are the primary glia cells of the peripheral nervous system, which play very important role in repairing after nerve injury. As the target cells of chronic hyperglycemia, SCs' functions, including the formation of myelin sheath, the secretion of neurotrophic factors, energy supplying for the axon, and the guidance of axon regeneration, etc., are damaged under the action of high glucose. The destroyed functions of SCs can inhibit the repair of damaged nerves and accelerate the progress of DPN. Therefore, if the damage of high glucose to SCs can be effectively reduced, it will provide a new way for the treatment of DPN and DFU and reduce the morbidity of DFU. This review focuses on the function of SCs and its relationship with DPN.
- Diabetic foot /
- Myelin sheath /
- Diabetic peripheral neuropathy /
- Schwann cells /
- Neurotrophic factors /
- Energy supply /
- Axonal regeneration
所有作者均声明不存在利益冲突

HTML全文

参考文献(39)

[1]	曹涛,计鹏,张智,等.抗生素骨水泥治疗糖尿病足溃疡的前瞻性随机对照研究[J].中华烧伤与创面修复杂志,2023,39(4):311-318.DOI: 10.3760/cma.j.cn501225-20221111-00485.
[2]	McDermottK,FangM,BoultonAJM,et al.Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers[J].Diabetes Care,2023,46(1):209-221.DOI: 10.2337/dci22-0043.
[3]	SenCK,RoyS,KhannaS.Diabetic peripheral neuropathy associated with foot ulcer: one of a kind[J/OL].Antioxid Redox Signal,2023(2023-01-25)[2023-07-27]. https://pubmed.ncbi.nlm.nih.gov/35850520/.DOI:10.1089/ars.2022.0093.[published online ahead of print].
[4]	ArmstrongDG,TanTW,BoultonA,et al.Diabetic foot ulcers: a review[J].JAMA,2023,330(1):62-75.DOI: 10.1001/jama.2023.10578.
[5]	SelvarajahD,KarD,KhuntiK,et al.Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention[J].Lancet Diabetes Endocrinol,2019,7(12):938-948.DOI: 10.1016/S2213-8587(19)30081-6.
[6]	HicksCW,SelvinE.Epidemiology of peripheral neuropathy and lower extremity disease in diabetes[J].Curr Diab Rep,2019,19(10):86.DOI: 10.1007/s11892-019-1212-8.
[7]	FeldmanEL,CallaghanBC,Pop-BusuiR,et al.Diabetic neuropathy[J].Nat Rev Dis Primers,2019,5(1):41.DOI: 10.1038/s41572-019-0092-1.
[8]	MizukamiH,OsonoiS.Pathogenesis and molecular treatment strategies of diabetic neuropathy collateral glucose-utilizing pathways in diabetic polyneuropathy[J].Int J Mol Sci,2020,22(1):94.DOI: 10.3390/ijms22010094.
[9]	CalcuttNA.Diabetic neuropathy and neuropathic pain: a (con)fusion of pathogenic mechanisms?[J].Pain,2020,161(Suppl 1):S65-86.DOI: 10.1097/j.pain.0000000000001922.
[10]	TangHY,JiangAJ,MaJL,et al.Understanding the signaling pathways related to the mechanism and treatment of diabetic peripheral neuropathy[J].Endocrinology,2019,160(9):2119-2127.DOI: 10.1210/en.2019-00311.
[11]	MinQ,ParkinsonDB,DunXP.Migrating Schwann cells direct axon regeneration within the peripheral nerve bridge[J].Glia,2021,69(2):235-254.DOI: 10.1002/glia.23892.
[12]	TaveggiaC,FeltriML.Beyond wrapping: canonical and noncanonical functions of Schwann cells[J].Annu Rev Neurosci,2022,45:561-580.DOI: 10.1146/annurev-neuro-110920-030610.
[13]	MonjeM.Myelin plasticity and nervous system function[J].Annu Rev Neurosci,2018,41:61-76.DOI: 10.1146/annurev-neuro-080317-061853.
[14]	ReedCB,FrickLR,WeaverA,et al.Deletion of calcineurin in Schwann cells does not affect developmental myelination, but reduces autophagy and delays myelin clearance after peripheral nerve injury[J].J Neurosci,2020,40(32):6165-6176.DOI: 10.1523/JNEUROSCI.0951-20.2020.
[15]	EscobarA,CarvalhoMR,MaiaFR,et al.Glial cell line-derived neurotrophic factor-loaded CMCht/PAMAM dendrimer nanoparticles for peripheral nerve repair[J].Pharmaceutics,2022,14(11):2408.DOI: 10.3390/pharmaceutics14112408.
[16]	KangWB,ChenYJ,LuDY,et al.Folic acid contributes to peripheral nerve injury repair by promoting Schwann cell proliferation, migration, and secretion of nerve growth factor[J].Neural Regen Res,2019,14(1):132-139.DOI: 10.4103/1673-5374.243718.
[17]	ContrerasE,BolívarS,NavarroX,et al.New insights into peripheral nerve regeneration: the role of secretomes[J].Exp Neurol,2022,354:114069.DOI: 10.1016/j.expneurol.2022.114069.
[18]	JhaMK,LeeY,RussellKA,et al.Monocarboxylate transporter 1 in Schwann cells contributes to maintenance of sensory nerve myelination during aging[J].Glia,2020,68(1):161-177.DOI: 10.1002/glia.23710.
[19]	JhaMK,MorrisonBM.Lactate transporters mediate glia-neuron metabolic crosstalk in homeostasis and disease[J].Front Cell Neurosci,2020,14:589582.DOI: 10.3389/fncel.2020.589582.
[20]	BabettoE,WongKM,BeirowskiB.A glycolytic shift in Schwann cells supports injured axons[J].Nat Neurosci,2020,23(10):1215-1228.DOI: 10.1038/s41593-020-0689-4.
[21]	YuanQ,ZhangX,WeiW,et al.Lycorine improves peripheral nerve function by promoting Schwann cell autophagy via AMPK pathway activation and MMP9 downregulation in diabetic peripheral neuropathy[J].Pharmacol Res,2022,175:105985.DOI: 10.1016/j.phrs.2021.105985.
[22]	LiuYP,ShaoSJ,GuoHD.Schwann cells apoptosis is induced by high glucose in diabetic peripheral neuropathy[J].Life Sci,2020,248:117459.DOI: 10.1016/j.lfs.2020.117459.
[23]	DuW,WangN,LiF,et al.STAT3 phosphorylation mediates high glucose-impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy[J].FASEB J,2019,33(7):8008-8021.DOI: 10.1096/fj.201900127R.
[24]	EidSA,El MassryM,HichorM,et al.Targeting the NADPH oxidase-4 and liver X receptor pathway preserves Schwann cell integrity in diabetic mice[J].Diabetes,2020,69(3):448-464.DOI: 10.2337/db19-0517.
[25]	FanB,LiC,SzaladA,et al.Mesenchymal stromal cell-derived exosomes ameliorate peripheral neuropathy in a mouse model of diabetes[J].Diabetologia,2020,63(2):431-443.DOI: 10.1007/s00125-019-05043-0.
[26]	ZhangQ,SongW,ZhaoB,et al.Quercetin attenuates diabetic peripheral neuropathy by correcting mitochondrial abnormality via activation of AMPK/PGC-1α pathway in vivo and in vitro[J].Front Neurosci,2021,15:636172.DOI: 10.3389/fnins.2021.636172.
[27]	GongX,GuiZ,YeX,et al.Jatrorrhizine ameliorates Schwann cell myelination via inhibiting HDAC3 ability to recruit Atxn2l for regulating the NRG1-ErbB2-PI3K-AKT pathway in diabetic peripheral neuropathy mice[J].Phytother Res,2023,37(2):645-657.DOI: 10.1002/ptr.7641.
[28]	SunQ,TangDD,YinEG,et al.Diagnostic significance of serum levels of nerve growth factor and brain derived neurotrophic factor in diabetic peripheral neuropathy[J].Med Sci Monit,2018,24:5943-5950.DOI: 10.12659/MSM.909449.
[29]	LiK,ShiX,LuoM,et al.Taurine protects against myelin damage of sciatic nerve in diabetic peripheral neuropathy rats by controlling apoptosis of Schwann cells via NGF/Akt/GSK3β pathway[J].Exp Cell Res,2019,383(2):111557.DOI: 10.1016/j.yexcr.2019.111557.
[30]	AnJ,ZhangX,JiaK,et al.Trichostatin A increases BDNF protein expression by improving XBP-1s/ATF6/GRP78 axis in Schwann cells of diabetic peripheral neuropathy[J].Biomed Pharmacother,2021,133:111062.DOI: 10.1016/j.biopha.2020.111062.
[31]	XiC,ZhangY,YanM,et al.Exogenous neuritin treatment improves survivability and functions of Schwann cells with improved outgrowth of neurons in rat diabetic neuropathy[J].J Cell Mol Med,2020,24(17):10166-10176.DOI: 10.1111/jcmm.15627.
[32]	ElafrosMA,AndersenH,BennettDL,et al.Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments[J].Lancet Neurol,2022,21(10):922-936.DOI: 10.1016/S1474-4422(22)00188-0.
[33]	ChandrasekaranK,AnjaneyuluM,ChoiJ,et al.Role of mitochondria in diabetic peripheral neuropathy: influencing the NAD+-dependent SIRT1-PGC-1α-TFAM pathway[J].Int Rev Neurobiol,2019,145:177-209.DOI: 10.1016/bs.irn.2019.04.002.
[34]	JhaMK,AmentXH,YangF,et al.Reducing monocarboxylate transporter MCT1 worsens experimental diabetic peripheral neuropathy[J].Exp Neurol,2020,333:113415.DOI: 10.1016/j.expneurol.2020.113415.
[35]	BouçanovaF,ChrastR.Metabolic interaction between Schwann cells and axons under physiological and disease conditions[J].Front Cell Neurosci,2020,14:148.DOI: 10.3389/fncel.2020.00148.
[36]	HackettAR,StricklandA,MilbrandtJ.Disrupting insulin signaling in Schwann cells impairs myelination and induces a sensory neuropathy[J].Glia,2020,68(5):963-978.DOI: 10.1002/glia.23755.
[37]	JiaoY,LiYZ,ZhangYH,et al.Lysine demethylase KDM5B down-regulates SIRT3-mediated mitochondrial glucose and lipid metabolism in diabetic neuropathy[J].Diabet Med,2023,40(1):e14964.DOI: 10.1111/dme.14964.
[38]	BelgradJ,De PaceR,FieldsRD.Autophagy in myelinating glia[J].J Neurosci,2020,40(2):256-266.DOI: 10.1523/JNEUROSCI.1066-19.2019.
[39]	YinY,QuH,YangQ,et al.Astragaloside IV alleviates Schwann cell injury in diabetic peripheral neuropathy by regulating microRNA-155-mediated autophagy[J].Phytomedicine,2021,92:153749.DOI: 10.1016/j.phymed.2021.153749.